Reducing the endotoxic activity of pertussis vaccine.
Unadsorbed, regular production pertussis vaccine was treated with polymyxin B sulphate at concentrations of 25, 50 and 100 microgram/ml. The toxic activity of treated and untreated vaccines was compared using both the limulus amoebocyte lysate test and the mouse-weight-gain test. Protective efficacy was also assessed by the mouse protection test. No discernible effect on either toxicity or efficacy of the pertussis vaccine was observed. When the vaccine was treated with 5000 microgram/ml of polymyxin, endotoxic activity assessed by the limulus lysate test appeared to be abolished.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004731:Endotoxins; D005260:Female; D008033:Limulus Test; D051379:Mice; D010567:Pertussis Vaccine / Q000627:therapeutic use / Q000633:toxicity*; D011112:Polymyxin B
D004731:Endotoxins; D010567:Pertussis Vaccine; D011112:Polymyxin B